Haoxi Health Technology completes $6.5 million registered direct offering

Haoxi Health Technology Ltd (NASDAQ: HAO) completed a $6.5 million registered direct offering, according to a statement from Univest Securities, which served as the sole placement agent.

The Beijing-based company, which provides online marketing solutions for healthcare industry clients, sold 9 million Class A ordinary shares and 16,999,998 pre-funded warrants at $0.25 per share. The pre-funded warrants carry an exercise price of $0.0026 per share, with each warrant exercisable for 10.355 shares.

The offering was conducted under a shelf registration statement on Form F-3 that was declared effective by the Securities and Exchange Commission on June 13, 2025. The gross proceeds of $6.5 million are before deducting placement agent fees and other offering expenses.

Haoxi Health Technology specializes in short-form video and news feed advertising across major Chinese digital platforms including Toutiao, Douyin, WeChat, and Sina Weibo. The company focuses on serving healthcare industry advertiser clients with online marketing solutions.

Univest Securities, a FINRA member firm based in New York, has been registered since 1994 and reports raising over $1.8 billion in capital for issuers globally since 2019 across approximately 100 transactions.

You May Also Be Interested In

• Haoxi Health closes $4M direct offering via Univest Securities
• Autonomix Medical raises $2.6M via warrant inducement agreement
• SEC clears S-4 for Olin and Huntsman all-stock merger